EUVIMEDEUVIMED entdecken
Crossref

Characterization of a Cytotoxic Transglutaminase from Mycobacterium spp. Driving RIPK1 Activation

Claire Martin, Julien Robert, Sophie Bernard, Antoine Girard

Bulletin of Pioneering Researches of Medical and Clinical Science · 2024 · 4 (2) · 167-176

DOI: 10.51847/cgqobhs5ci ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Pioneering Researches of Medical and Clinical Science, 2024. Verfasst von Claire Martin und 3 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Martin, C., Robert, J., Bernard, S., & Girard, A. (2024). Characterization of a Cytotoxic Transglutaminase from Mycobacterium spp. Driving RIPK1 Activation. Bulletin of Pioneering Researches of Medical and Clinical Science, 4(2), 167-176. https://doi.org/10.51847/cgqobhs5ci

Vancouver

Martin C, Robert J, Bernard S, Girard A. Characterization of a Cytotoxic Transglutaminase from Mycobacterium spp. Driving RIPK1 Activation. Bulletin of Pioneering Researches of Medical and Clinical Science. 2024;4(2):167-176. doi:10.51847/cgqobhs5ci

BibTeX
@article{Martin2024,
  author = {Martin, Claire and Robert, Julien and Bernard, Sophie and Girard, Antoine},
  title = {Characterization of a Cytotoxic Transglutaminase from Mycobacterium spp. Driving RIPK1 Activation},
  journal = {Bulletin of Pioneering Researches of Medical and Clinical Science},
  year = {2024},
  volume = {4},
  number = {2},
  pages = {167--176},
  doi = {10.51847/cgqobhs5ci}
}
Kostenlos starten →